6.38 USD
▼-0.61-8.73%
盘后 6.38 0.00%
2026-11-20
市值
$25.08M
市盈率
—
EPS
-22.48
股息率
—
52 周区间
6.02 – 31.62
成交量
61.03K
Beta
3.44
目标价
41.43
52W 低 6.0252W 高 31.62
价格走势
公司简介
Pelthos Therapeutics Inc., a bio-pharmaceutical company, develops and commercializes therapeutic products to help patients with unmet treatment burdens. The company offers ZELSUVMI for the treatment of molluscum contagiosum in adults and children 1 year of age and older; XEPI, (ozenoxacin) cream, a quinolone antimicrobial for the treatment of impetigo due to Staphylococcus aureus or Streptococcus pyogenes in adult and pediatric patients 2 months of age and older; and XEGLYZE, a pediculicide indicated for topical treatment of head lice infestati...